Home Webinars CEORoadshow 2022 Webinar Series Presents Awakn Life Sciences (OTCQB: AWKNF)

CEORoadshow 2022 Webinar Series Presents Awakn Life Sciences (OTCQB: AWKNF)

25
0

Welcome to the CEO Roadshow Webinar Series where we feature small and mid-cap stocks that may be undervalued or have other upcoming catalysts that make them a potential long-term investment opportunity.

In this series, we will be joined by Mr. Anthony Tennyson, CEO and Co-founder of Awakn Life Sciences Corp. a biotechnology company, researching, developing, and commercializing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder.

Mr. Tennyson is an experienced financial services industry executive with 10 years in international strategy, commercial leadership roles with Aon plc, and 5 years with Merrill Lynch and Bank of Ireland. Anthony holds an MBA in Strategy and Finance and an MSc in Technology both from UCD, Ireland’s top-ranked business school.

They trade under (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’)

To register for or join any of the upcoming webinars, please click on the individual link below for the dates you would like to attend and register.

  • Webinar 1
  • Webinar 2
  • Webinar 3
  • Webinar 4
  • Webinar 5
  • Webinar 6

About Awakn Life Sciences Corp.

Awakn Life Sciences Corp. is a revenue-generating biotechnology company researching, developing, and commercialising therapeutics to treat substance and behavioral addictions. Awakn has a near-term focus on Alcohol Use Disorder (AUD), a condition affecting 400m people globally for which the current standard of care is inadequate. Our goal is to provide effective therapeutics to addiction sufferers in desperate need and our strategy is focused on commercializing our R&D pipeline across multiple channels.

Contact CEOROADSHOW.COM

Mike Elliott
me@CEOROADSHOW.COM

Disclaimer

CEOROADSHOW content and productions are based on data obtained from sources we believe to be reliable but are not guaranteed as to the accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor.

Any opinions expressed in CEOROADSHOW content and productions, or other investor relations materials and presentations are subject to change. Neither CEOROADSHOW nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. All data and information are provided for informational or entertainment purposes only. CEOROADSHOW is not a registered broker-dealer or a registered investment advisor.

CEORoadshow.com is committed to providing our readers with useful information on publicly traded companies. CEORoadshow.com sometimes contracts with third parties or publicly traded companies and receives compensation from them in the form of cash as payment for publishing information and opinions about the company and the trading market for their securities.

CEORoadshow.com content should not be considered to be independent publications concerning the company. CEORoadshow was paid a fee by Awakn Life Sciences for the preparation of this webinar series.

#investing #stocks #stockmarket

LEAVE A REPLY

Please enter your comment!
Please enter your name here